[Takeoff #10] Becoming a PEPR Grant Recipient

[Article, Video] - Published on December 11, 2025 in Major Programs, Development

Farida Djouad is a researcher at the Institute of Regenerative Medicine and Biotherapy (IRMB). As part of the PEPR Ichondro program, she is developing a cell-based therapy aimed at repairing joint cartilage damage in patients. This project, funded by the ANR, receives support designed to strengthen strategic initiatives in scientific research in France. She discusses it with us in the “Décollage” series produced by the Department of Innovation and Partnerships (Dipa) at the University of Montpellier.

It was while working with zebrafish that Farida Djouad came to understand the central role of neural crest-derived cells in cartilage regeneration. Based on this discovery, the Ichondro project was launched,with the goal of“developing an innovative cell therapy product using induced pluripotent stem cells differentiated into neural crest cells to repair defects in articular cartilage in patients,” explains theInserm research director. This project brings together a national ecosystem, working in close collaboration with hospitals, national research infrastructures, and academic research centers.

When applying for PEPR funding, Farida Djouad turned to Dipa, which supported her from the earliest stages of project development through to drafting the invention disclosures to protect her discoveries.“PEPR programs act as catalysts: they help accelerate our research by bridging the gap from basic research to clinical research. They also represent, in my view, a unique opportunity to build strong national networks that bring together the diverse expertise we have here in France.”

Keywords: Takeoff, Innovation